Heart drug after ablation: did it prevent AFib return?
NCT ID NCT04704050
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the drug dronedarone could prevent atrial fibrillation (AFib) from coming back after a heart ablation procedure. About 22 adults with AFib who had ablation were randomly given either dronedarone or a placebo. The goal was to see if the drug reduced irregular heartbeats and scarring in the heart. The study was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Tulane University School of Medicine
New Orleans, Louisiana, 70112, United States
-
University of Colorado Health Memorial
Colorado Springs, Colorado, 80909, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Could a new injection tame atrial fibrillation?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Can a cholesterol drug keep atrial fibrillation at bay after ablation?
- Can a One-Two punch fix a leaky heart valve and restore normal rhythm?
- Could a guided Self-Care plan tame atrial Fibrillation's return?